Bayer sees profit peak in pharma segment

Bayer's pharmaceutical segment sees high profits and expected higher earnings. New drugs drive strong sales and profitability. Investors respond positively to the outlook.

https://www.faz.net/aktuell/wirtschaft/unternehmen/bayer-sieht-den-wendepunkt-erreicht-201646732.html

Image:

#bayer #pharmaceuticals #profits #drugs